🇺🇸 FDA
Patent

US 7576076

Modified pyrimidine glucocorticoid receptor modulators

granted A61KA61K31/506A61K31/513

Quick answer

US patent 7576076 (Modified pyrimidine glucocorticoid receptor modulators) held by Corcept Therapeutics Incorporated expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Corcept Therapeutics Incorporated
Grant date
Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/506, A61K31/513, A61K31/551, A61P